Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Asou

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
International Journal of Hematology|January 22, 2000
Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991M Yoshida, K Tsubaki, T Kobayashi, et al.
British Journal of Haematology|January 29, 2000
Quantitative expression of erythropoietin receptor (EPO-R) on acute leukaemia cells: relationships between the amount of EPO-R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clinical prognosis. Japan Adult Leukaemia Study GroupA Takeshita, K Shinjo, M Higuchi, et al.
Leukemia|January 19, 2000
Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemiaT Yokozawa, M Towatari, H Iida, et al.
European Journal of Haematology|July 29, 2000
Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemiaY Nakano, T Naoe, H Kiyoi, et al.
Leukemia|October 17, 2003
Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtypeN Matsuno, M Osato, N Yamashita, et al.
Leukemia|February 13, 2002
Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapyT Naoe, Y Tagawa, H Kiyoi, et al.
Blood|April 27, 1999
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemiaH Kiyoi, T Naoe, Y Nakano, et al.
Clinical and Diagnostic Laboratory Immunology|September 3, 1999
Detection of borna disease virus-reactive antibodies from patients with psychiatric disorders and from horses by electrochemiluminescence immunoassayK Yamaguchi, T Sawada, T Naraki, et al.
Leukemia|July 9, 2011
Eμ/miR-125b transgenic mice develop lethal B-cell malignanciesY Enomoto, J Kitaura, K Hatakeyama, et al.
Blood|April 6, 2001
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignanciesY Yamamoto, H Kiyoi, Y Nakano, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
International Journal of Hematology|January 22, 2000
Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991M Yoshida, K Tsubaki, T Kobayashi, et al.
British Journal of Haematology|January 29, 2000
Quantitative expression of erythropoietin receptor (EPO-R) on acute leukaemia cells: relationships between the amount of EPO-R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clinical prognosis. Japan Adult Leukaemia Study GroupA Takeshita, K Shinjo, M Higuchi, et al.
Leukemia|January 19, 2000
Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemiaT Yokozawa, M Towatari, H Iida, et al.
European Journal of Haematology|July 29, 2000
Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemiaY Nakano, T Naoe, H Kiyoi, et al.
Leukemia|October 17, 2003
Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtypeN Matsuno, M Osato, N Yamashita, et al.
Leukemia|February 13, 2002
Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapyT Naoe, Y Tagawa, H Kiyoi, et al.
Blood|April 27, 1999
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemiaH Kiyoi, T Naoe, Y Nakano, et al.
Clinical and Diagnostic Laboratory Immunology|September 3, 1999
Detection of borna disease virus-reactive antibodies from patients with psychiatric disorders and from horses by electrochemiluminescence immunoassayK Yamaguchi, T Sawada, T Naraki, et al.
Leukemia|July 9, 2011
Eμ/miR-125b transgenic mice develop lethal B-cell malignanciesY Enomoto, J Kitaura, K Hatakeyama, et al.
Blood|April 6, 2001
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignanciesY Yamamoto, H Kiyoi, Y Nakano, et al.
Pageof 13